Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_1
2
40%
Ph phase_4
1
20%
Ph not_applicable
2
40%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (40.0%)
Phase 41 (20.0%)
N/A2 (40.0%)

Trials by Status

completed480%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
completednot_applicable

KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

NCT06566794
recruitingnot_applicable

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

NCT03675412
completedphase_1

A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants

NCT06215430
completedphase_4

Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion

NCT04950660
completedphase_1

Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue

NCT01944215

Clinical Trials (5)

Showing 5 of 5 trials
NCT06566794Not Applicable

KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

Completed
NCT03675412Not Applicable

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Recruiting
NCT06215430Phase 1

A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants

Completed
NCT04950660Phase 4

Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion

Completed
NCT01944215Phase 1

Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5